Yu-Ru Lee
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
- RNA modifications and cancer
- CRISPR and Genetic Engineering
Papers in
-
- Ubiquitin and proteasome pathways 6
- Enzyme Catalysis and Immobilization 4
- Cancer therapeutics and mechanisms 3
- PI3K/AKT/mTOR signaling in cancer 3
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Pier Paolo Pandolfi (5 shared papers)Ming Chen (1 shared paper)Ruey‐Hwa Chen (6 shared papers)Wei-Chien Yuan (5 shared papers)Chun-Hau Chen (3 shared papers)Hsin‐Yi Chen (2 shared papers)Hsiu‐Ming Shih (1 shared paper)Jonathan D. Lee (2 shared papers)
- Journals
- Molecular Cell (3 papers)Fermentation (2 papers)Arabian Journal of Chemistry (2 papers)PLoS ONE (2 papers)APOPTOSIS (1 paper)
- Partner nations
- TaiwanUnited StatesItaly
In The Last Decade
Yu-Ru Lee
38 papers receiving 2.0k citations
Yu-Ru Lee's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 394
- Molecular Biology 1.4k
- Oncology 310
- Toxicology 31
- Cell Biology 150
Countries citing papers authored by Yu-Ru Lee
This map shows the geographic impact of Yu-Ru Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Ru Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Ru Lee more than expected).
Fields of papers citing papers by Yu-Ru Lee
This network shows the impact of papers produced by Yu-Ru Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Ru Lee. The network helps show where Yu-Ru Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu-Ru Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The functions and regulation of the PTEN tumour suppressor: new modes and prospects Hit paper breakdown → | 2018 | 673 |
| 2 | 2018 | 244 | |
| 3 | 2011 | 158 | |
| 4 | 2014 | 145 | |
| 5 | 2010 | 106 | |
| 6 | 2007 | 65 | |
| 7 | 2019 | 63 | |
| 8 | 2020 | 57 | |
| 9 | 2024 | 49 | |
| 10 | 2013 | 46 | |
| 11 | 1999 | 41 | |
| 12 | 2012 | 32 | |
| 13 | 2015 | 31 | |
| 14 | 1997 | 30 | |
| 15 | 2013 | 24 | |
| 16 | 1996 | 19 | |
| 17 | 2024 | 17 | |
| 18 | 2021 | 17 | |
| 19 | 2017 | 17 | |
| 20 | 2016 | 16 |
About Yu-Ru Lee
Yu-Ru Lee is a scholar working on Molecular Biology, Cancer Research, Toxicology, Renewable Energy, Sustainability and the Environment and Organic Chemistry, having authored 39 papers that have together received 2.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Algal biology and biofuel production (5 papers), Enzyme Catalysis and Immobilization (4 papers), Biodiesel Production and Applications (4 papers), Synthesis and biological activity (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer therapeutics and mechanisms (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (394 citations), Molecular Biology (1.4k citations), Oncology (310 citations), Toxicology (31 citations) and Cell Biology (150 citations). Yu-Ru Lee has collaborated with scholars based in Taiwan, United States and Italy. Frequent co-authors include Pier Paolo Pandolfi, Ming Chen, Ruey‐Hwa Chen, Wei-Chien Yuan, Chun-Hau Chen, Hsin‐Yi Chen, Hsiu‐Ming Shih, Jonathan D. Lee, John G. Clohessy and Wen‐Tien Tsai. Their work appears in journals such as Molecular Cell, Fermentation, Arabian Journal of Chemistry, PLoS ONE and APOPTOSIS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.